{"id":68212,"date":"2026-06-15T21:35:41","date_gmt":"2026-06-15T13:35:41","guid":{"rendered":"https:\/\/flcube.com\/?p=68212"},"modified":"2026-06-15T21:35:42","modified_gmt":"2026-06-15T13:35:42","slug":"medtronic-completes-550-million-acquisition-of-scientia-vascular-to-strengthen-neurovascular-portfolio","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=68212","title":{"rendered":"Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Medtronic (<a href=\"https:\/\/www.google.com\/finance\/quote\/MDT:NYSE\">NYSE: MDT<\/a>)<\/strong> announced on June 12, 2026 the completion of its acquisition of <strong>Scientia Vascular<\/strong>, a privately-held medical device company based in <strong>Salt Lake City<\/strong>, for <strong>$550 million<\/strong>, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition. The transaction enhances Medtronic&#8217;s neurovascular capabilities with Scientia&#8217;s best-in-class access products for complex neurovascular procedures.<\/p>\n\n\n\n<h2 id=\"h-transaction-details\" class=\"wp-block-heading\">Transaction Details<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>Value<\/th><\/tr><\/thead><tbody><tr><td><strong>Acquirer<\/strong><\/td><td>Medtronic plc (NYSE: MDT)<\/td><\/tr><tr><td><strong>Target<\/strong><\/td><td>Scientia Vascular (private)<\/td><\/tr><tr><td><strong>Location<\/strong><\/td><td>Salt Lake City, Utah<\/td><\/tr><tr><td><strong>Transaction Value<\/strong><\/td><td>$550 million (subject to customary adjustments)<\/td><\/tr><tr><td><strong>Additional Consideration<\/strong><\/td><td>Undisclosed earn-out and milestone payments<\/td><\/tr><tr><td><strong>Closing Date<\/strong><\/td><td>June 12, 2026<\/td><\/tr><tr><td><strong>Strategic Rationale<\/strong><\/td><td>Neurovascular portfolio enhancement<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-product-portfolio-integration\" class=\"wp-block-heading\">Product Portfolio Integration<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Scientia&#8217;s Core Products:<\/strong> Guidewires and catheters for neurovascular access<\/li>\n\n\n\n<li><strong>Key Differentiation:<\/strong> Best-in-class access products enabling simplicity for physicians<\/li>\n\n\n\n<li><strong>Integration Strategy:<\/strong> Seamless compatibility with Medtronic&#8217;s existing neurovascular suite<\/li>\n\n\n\n<li><strong>Procedural Coverage:<\/strong> Strengthens support across full neurovascular procedural workflow<\/li>\n\n\n\n<li><strong>Clinical Focus:<\/strong> Complex neurovascular conditions requiring advanced access solutions<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-strategic-market-positioning\" class=\"wp-block-heading\">Strategic Market Positioning<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Aspect<\/th><th>Impact<\/th><\/tr><\/thead><tbody><tr><td><strong>Neurovascular Market<\/strong><\/td><td>Addresses growing demand for minimally invasive stroke and aneurysm treatments<\/td><\/tr><tr><td><strong>Competitive Advantage<\/strong><\/td><td>Enhanced procedural workflow integration from access to treatment<\/td><\/tr><tr><td><strong>Physician Support<\/strong><\/td><td>Comprehensive solution reducing need for multiple vendor products<\/td><\/tr><tr><td><strong>Innovation Pipeline<\/strong><\/td><td>Access to Scientia&#8217;s development capabilities in neurovascular access devices<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-financial-amp-operational-implications\" class=\"wp-block-heading\">Financial &amp; Operational Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Revenue Synergies:<\/strong> Cross-selling opportunities across Medtronic&#8217;s global neurovascular customer base<\/li>\n\n\n\n<li><strong>Operational Integration:<\/strong> Scientia team and operations expected to integrate into Medtronic&#8217;s Neuroscience portfolio<\/li>\n\n\n\n<li><strong>R&amp;D Enhancement:<\/strong> Strengthened innovation pipeline in neurovascular access technologies<\/li>\n\n\n\n<li><strong>Market Expansion:<\/strong> Leverage Medtronic&#8217;s global distribution network for Scientia products<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-neurovascular-market-context\" class=\"wp-block-heading\">Neurovascular Market Context<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Growth:<\/strong> Global neurovascular devices market projected to exceed <strong>$4 billion by 2028<\/strong><\/li>\n\n\n\n<li><strong>Clinical Trends:<\/strong> Increasing adoption of endovascular approaches for stroke, aneurysms, and other cerebrovascular conditions<\/li>\n\n\n\n<li><strong>Access Challenges:<\/strong> Complex anatomy often requires specialized guidewires and catheters for successful navigation<\/li>\n\n\n\n<li><strong>Workflow Integration:<\/strong> Growing physician preference for single-vendor solutions across complete procedures<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-strategic-rationale-amp-long-term-vision\" class=\"wp-block-heading\">Strategic Rationale &amp; Long-term Vision<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">This acquisition aligns with Medtronic&#8217;s strategy to provide <strong>comprehensive solutions<\/strong> across the entire neurovascular procedural workflow. By adding Scientia&#8217;s specialized access products to its existing portfolio of treatment devices, Medtronic can offer physicians a more integrated approach to managing complex neurovascular cases, potentially improving procedural efficiency and clinical outcomes.<\/p>\n\n\n\n<h2 id=\"h-next-steps-amp-integration-timeline\" class=\"wp-block-heading\">Next Steps &amp; Integration Timeline<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Immediate Integration:<\/strong> Scientia products to be incorporated into Medtronic&#8217;s commercial offerings<\/li>\n\n\n\n<li><strong>Global Rollout:<\/strong> International market expansion leveraging Medtronic&#8217;s established distribution channels<\/li>\n\n\n\n<li><strong>R&amp;D Collaboration:<\/strong> Joint development initiatives to enhance next-generation neurovascular access technologies<\/li>\n\n\n\n<li><strong>Customer Transition:<\/strong> Seamless transition for existing Scientia customers to Medtronic support infrastructure<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding acquisition integration, market opportunities, and financial expectations. Actual results may differ due to risks including integration challenges, competitive dynamics, and market acceptance.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medtronic (NYSE: MDT) announced on June 12, 2026 the completion of its acquisition of Scientia&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[233,1031],"class_list":["post-68212","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-medtronic","tag-nyse-mdt"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Medtronic (NYSE: MDT) announced on June 12, 2026 the completion of its acquisition of Scientia Vascular, a privately-held medical device company based in Salt Lake City, for $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition. The transaction enhances Medtronic&#039;s neurovascular capabilities with Scientia&#039;s best-in-class access products for complex neurovascular procedures.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=68212\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio\" \/>\n<meta property=\"og:description\" content=\"Medtronic (NYSE: MDT) announced on June 12, 2026 the completion of its acquisition of Scientia Vascular, a privately-held medical device company based in Salt Lake City, for $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition. The transaction enhances Medtronic&#039;s neurovascular capabilities with Scientia&#039;s best-in-class access products for complex neurovascular procedures.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=68212\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-15T13:35:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-15T13:35:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68212#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68212\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio\",\"datePublished\":\"2026-06-15T13:35:41+00:00\",\"dateModified\":\"2026-06-15T13:35:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68212\"},\"wordCount\":452,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Medtronic\",\"NYSE: MDT\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=68212#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68212\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=68212\",\"name\":\"Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-06-15T13:35:41+00:00\",\"dateModified\":\"2026-06-15T13:35:42+00:00\",\"description\":\"Medtronic (NYSE: MDT) announced on June 12, 2026 the completion of its acquisition of Scientia Vascular, a privately-held medical device company based in Salt Lake City, for $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition. The transaction enhances Medtronic's neurovascular capabilities with Scientia's best-in-class access products for complex neurovascular procedures.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68212#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=68212\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68212#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio - Insight, China&#039;s Pharmaceutical Industry","description":"Medtronic (NYSE: MDT) announced on June 12, 2026 the completion of its acquisition of Scientia Vascular, a privately-held medical device company based in Salt Lake City, for $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition. The transaction enhances Medtronic's neurovascular capabilities with Scientia's best-in-class access products for complex neurovascular procedures.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=68212","og_locale":"en_US","og_type":"article","og_title":"Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio","og_description":"Medtronic (NYSE: MDT) announced on June 12, 2026 the completion of its acquisition of Scientia Vascular, a privately-held medical device company based in Salt Lake City, for $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition. The transaction enhances Medtronic's neurovascular capabilities with Scientia's best-in-class access products for complex neurovascular procedures.","og_url":"https:\/\/flcube.com\/?p=68212","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-15T13:35:41+00:00","article_modified_time":"2026-06-15T13:35:42+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=68212#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=68212"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio","datePublished":"2026-06-15T13:35:41+00:00","dateModified":"2026-06-15T13:35:42+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=68212"},"wordCount":452,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Medtronic","NYSE: MDT"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=68212#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=68212","url":"https:\/\/flcube.com\/?p=68212","name":"Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-06-15T13:35:41+00:00","dateModified":"2026-06-15T13:35:42+00:00","description":"Medtronic (NYSE: MDT) announced on June 12, 2026 the completion of its acquisition of Scientia Vascular, a privately-held medical device company based in Salt Lake City, for $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition. The transaction enhances Medtronic's neurovascular capabilities with Scientia's best-in-class access products for complex neurovascular procedures.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=68212#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=68212"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=68212#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/68212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=68212"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/68212\/revisions"}],"predecessor-version":[{"id":68214,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/68212\/revisions\/68214"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=68212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=68212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=68212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}